Serum levels of cytokines, glucose, and hemoglobin as possible predictors of poststroke depression, and association with poststroke fatigue

International Journal of Neuroscience

Volumn 122, Issue 11, 2012, Pages 682-690

  Ormstad, Heidi ^a,b   Aass, Hans Christian Dalsbotten ^c   Amthor, Karl Friedrich ^a   Lund Sorensen, Niels ^a   Sandvik, Leiv ^c  

^a VESTRE VIKEN HOSPITAL TRUST   (Norway)

^b UNIVERSITY OF SOUTH EASTERN NORWAY   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acute ischemic stroke; Level of cytokines; Level of glucose; Poststroke depression; Poststroke fatigue

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; GAMMA INTERFERON; GLUCOSE; HEMOGLOBIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BARTHEL INDEX 20; BECK DEPRESSION INVENTORY; BLOOD COMPONENT; BRAIN ISCHEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; FATIGUE; FATIGUE SEVERITY SCALE SCORE; FEMALE; GLUCOSE BLOOD LEVEL; HEMISPHERIC DOMINANCE; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PREDICTION; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD GLUCOSE; COHORT STUDIES; CYTOKINES; DEPRESSION; FATIGUE; FEMALE; HEMOGLOBINS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; STROKE;

EID: 84867535123     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2012.709892     Document Type: Article

References (43)

1. HackettML, Yapa C, Parag V, Anderson CS. Frequency of depression after stroke: A systematic review of observational studies. Stroke. 2005;36:1330-40.
2. Wade DT, Legh-Smith J, Hewer RA. Depressed mood after stroke. A community study of its frequency. Br J Psychiatry. 1987;151:200-5.
3. House A, Dennis M, Mogridge L, Warlow C, Hawton K, Jones L. Mood disorders in the year after first stroke. Br J Psychiatry. 1991;158:83-92.
4. Hackett ML, Anderson CS, House A, Halteh C. Interventions for preventing depression after stroke. Cochrane Database Syst Rev. 2008;CD003689.
5. Spalletta G, Bossu P, Ciaramella A, Bria P, Caltagirone C, Robinson RG. The etiology of poststroke depression: A review of the literature and a new hypothesis involving inflammatory cytokines. Mol Psychiatry. 2006;11:984-91.
6. van der Werf SP, van den Broek HL, Anten HW, Bleijenberg G. Experience of severe fatigue long after stroke and its relation to depressive symptoms and disease characteristics. Eur Neurol. 2001;45:28-33.
7. Ingles JL, Eskes GA, Phillips SJ. Fatigue after stroke. Arch Phys Med Rehabil. 1999;80:173-8.
8. Ormstad H, Aass HCD, Lund-Sensen N, Amthor KF, Sandvik L. Serum cytokine and glucose levels as predictors of poststroke fatigue in acute ischemic stroke patients. J Neurol. 2011;258:670-6.
9. Lerdal A, Bakken LN, Rasmussen EF, Beiermann C, Ryen S, Pynten S, Drefvelin AS, Dahl AM, Rognstad G, Finset A, Lee KA, Kim HS. Physical impairment, depressive symptoms and pre-stroke fatigue are related to fatigue in the acute phase after stroke. Disabil Rehabil. 2011;33:334-42.
10. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd. Classification of subtype of acute ischemic stroke.Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41.
11. Collin C, Wade DT, Davies S, Horne, V. The Barthel ADL index: A reliability study. Int Disabil Stud. 1988;10:61-3.
12. Wolfe CDA, Taub NA, Woodrow EJ, Burney PG. Assessment of scales of disability and handicap for stroke patients. Stroke. 1996;22:1242-4.
13. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121-3.
14. Choi-Kwon S, Han SW, Kwon SU, Kim JS. Poststroke fatigue: Characteristics and related factors. Cerebrovasc Dis. 2005;19:84-90.
15. Naess H, Nyland HI, Thomassen L, Aarseth J, Myhr KM. Fatigue at long-term follow-up in young adults with cerebral infarction. Cerebrovasc Dis. 2005;20:245-50.
16. Michael KM, Allen JK, Macko RF. Fatigue after stroke: Relationship to mobility, fitness, ambulatory activity, social support, and falls efficacy. Rehabil Nurs. 2006;31:210-7.
17. Naess H, Waje-Andreassen U, Thomassen L, Nyland H, Myhr KM. Health-related quality of life among young adults with ischemic stroke on long-term follow-up. Stroke. 2006;37: 1232-6.
18. Schepers VP, Visser-Meily AM, Ketelaar M, Lindeman E. Poststroke fatigue: Course and its relation to personal and stroke-related factors. Arch Phys Med Rehabil. 2006;87: 184-8.
19. Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. J Pers Assess. 1996;67:588-97.
20. Aben I, Verhey F, Lousberg R, Lodder J, Honig A. Validity of the Beck depression inventory, hospital anxiety and depression scale, SCL-90, and Hamilton depression rating scale as screening instruments for depression in stroke patients. Psychosomatics. 2002;43:386-93.
21. Poynter B, ShumanM,Diaz-Granados N, KapralM,Grace SL, Stewart DE. Sex differences in the prevalence of post-stroke depression: A systematic review. Psychosomatics. 2009;50: 563-9.
22. Hadidi N, Treat-Jacobson DJ, Lindquist R. Poststroke depression and functional outcome: A critical review of literature. Heart Lung. 2009;38:151-62.
23. KauhanenM, Korpelainen JT, Hiltunen P, Brusin E,Mononen H, Mtt R, Nieminen P, Sotaniemi KA, Myllyl W. Poststroke depression correlates with cognitive impairment and neurological deficits. Stroke. 1999;30:1875-80.
24. Gillen R, Tennen H, McKee TE, Gernert-Dott P, Affleck G. Depressive symptoms and history of depression predict rehabilitation efficiency in stroke patients. Arch Phys Med Rehabil. 2001;82:1645-9.
25. Robinson RG, Starr LB, Kubos KL, Price TR. A two-year longitudinal study of post-stroke mood disorders: Findings during the initial evaluation. Stroke. 1983;14:736-41.
26. Verdelho A,Hnon H, Lebert F, Pasquier F, Leys D. Depressive symptoms after stroke and relationship with dementia: A threeyear follow-up study. Neurology. 2004;62:905-11.
27. NysGM, van ZandvoortMJ, van derWorp HB, de Haan EH, de Kort PL, Kappelle LJ. Early depressive symptoms after stroke: Neuropsychological correlates and lesion characteristics. J Neurol Sci. 2005;228:27-33.
28. Robinson RG, Spalletta G. Poststroke depression: A review. Can J Psychiatry. 2010;55:341-9.
29. Scott JF, RobinsonGM, French JM, O'Connell JE, Alberti KG, Gray CS. Prevalence of admission hyperglycemia across clinical subtypes of acute stroke. Lancet. 1999;353:376-7.
30. Capes SE, Hunt D, MalmbergK, Pathak P,GersteinHC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: A systematic overview. Stroke. 2001;32:2426-32.
31. Gilmore RM, Stead LG. The role of hyperglycemia in acute ischemic stroke. Neurocrit Care. 2006;5:153-8.
32. Fuentes B, Diz-Tejedor E. General care in stroke: Relevance of glycemia and blood pressure levels. Cerebrovasc Dis. 2007;24:134-42.
33. Lustman PJ, Clouse RE. Depression in diabetic patients: The relationship between mood and glycemic control. J Diabetes Complications. 2005;19:113-22.
34. Schildkraut JJ, Kety SS. Biogenic amines and emotion. Science. 1976;156:21-37.
35. Hashimoto K. Emerging role of glutamate in the pathophysiology of major depressive disorder. Brain Res Rev. 2009;61:105-23.
36. Ramakrishnan R, Prabhakaran K, Jayakumar AR, Gunasekaran P, Sheeladevi R, Suthanthirarajan N. Involvement of Ca2+/calmodulin-dependent protein kinase II in the modulation of indolamines in diabetic and hyperglycemic rats. Neurosci Res. 2005;80:518-28.
37. Wang X, Li YH, Li MH, Lu J, Zhao JG, Sun XJ, Zhang B, Ye JL. Glutamate level detection by magnetic resonance spectroscopy in patients with post-stroke depression. Eur Arch Psychiatry Clin Neurosci. 2012;262:33-8 [Epub 2011 March 18].
38. Kagansky N, Levy S, Knobler H. The role of hyperglycemia in acute stroke. Arch Neurol. 2001;58:1209-12.
39. Roscoe JA, Morrow GR, Hickok JT, Mustian KM, Griggs JJ, Matteson SE, Bushunow P, Qazi R, Smith B. Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat. 2005;89:243-9.
40. Morrow GR, Hickok JT, Roscoe JA, Raubertas RF, Andrews PL, Flynn PJ, Hynes HE, Banerjee TK, Kirshner JJ, King DK; University of Rochester Cancer Center Community Clinical Oncology Program. Differential effects of paroxetine on fatigue and depression: A randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol. 2003;21: 4635-41.
41. Dantzer R, Kelley KW. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun. 2007;21:153-60.
42. Dantzer R. Cytokine, sickness behavior, and depression. Immunol Allergy Clin North Am. 2009;29:247-64.
43. Dantzer R, O'Connor JC, Lawson MA, Kelley KW. Inflammation-associated depression: From serotonin to kynurenine. Psychoneuroendocrinology. 2011;36:426-36.